continuous health monitoring News
-
BioIntelliSense Joins Polaris Dawn Mission to Advance Understanding of Human Health in Space
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its partnership with the Translational Research Institute for Space Health (TRISH) to further understanding of human health in space. The BioButton® medical grade wearable device will be used for commercial spaceflight research programs and notably during the upcoming five-day Polaris Dawn ...
-
BioIntelliSense Launches Patented, FDA-cleared Pulse Oximetry (SpO2) Sensor Technology that Addresses Skin Pigmentation and Motion Monitoring Challenges
Breakthrough pulse oximetry (SpO2 ) optical sensor solution offers medical-grade accuracy of oxygen level measurement across skin tones and while in motion Patented SpO2 sensor chipset, integrated processing and reference design capability to power the next generation of medical and consumer wearable devices BioIntelliSense, a continuous health monitoring and clinical intelligence company, ...
-
Showcase
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable
BOSTON, Nov. 6, 2020 /PRNewswire/ -- Empatica has been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to deploy a wearable and algorithm that enable the early and pre-symptomatic detection of COVID-19. The project's focus is on protecting the health of the general population by preventing outbreaks via early detection and alerting. Empatica's Aura algorithm gives a ...
-
Ardent Health Services and BioIntelliSense Launch State-of-the-Art Continuous Inpatient Monitoring Initiative to Advance Care and Optimize Workflow
Clinicians at Ardent’s BSA Hospital in Amarillo, Texas, began using the BioButton wearable device and BioCloud analytics engine in September to automate the collection of inpatient vital signs in general care units and increase both patient and clinician satisfaction. With plans for expansion across Ardent’s 30 hospitals, the program also leverages BioIntelliSense’s FDA-cleared ...
-
BioIntelliSense Acquires AlertWatch Clinical Intelligence Engine to Expand its Comprehensive Portfolio of Continuous Patient Monitoring Solutions
BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced its acquisition of AlertWatch®, an FDA-cleared, clinically proven patient monitoring solution. AlertWatch uniquely provides robust integration, data analysis and a patented intuitive display of contextual patient data for more efficient, actionable clinical decisions. As part of the recently ...
-
Thermo Fisher Scientific Supports COVID-19 Testing at Historically Black Colleges and Universities Seeking to Provide a Safe Return to Campus
Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, has committed to supporting the efforts of historically black colleges and universities (HBCUs) in the U.S. to make COVID-19 testing available to all returning students, faculty and staff at the beginning of the fall semester. Through an initiative called "The Just Project," named after pioneering biologist Ernest ...
-
Injectsense Receives Breakthrough Device Program Designation from FDA, Highlights Eye Sensor Performance and Path to Human Studies
Injectsense, a company focused on sensor-enabled digital health, announced it has received a Breakthrough Device Program (BDP) designation from the U.S. Food and Drug Administration (FDA) for its chronic continuous IOP monitoring system for glaucoma patients. The company’s IOP Connect™ system is based on a long-term implantable sensor, smaller than a grain of rice, that is delivered ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you